Back

Experimental evidences of conventional drugs efficacy in counteracting aortic fibrosis and new possible approaches for a better prognosis and a personalized management of Marfan patients

14 March 2025 (12:55 - 13:55)
Organised by: Logo
Congress Presentation Part of: Embracing diversity in intensive cardiac care Aortic Aneurysm, Thoracic ACVC Premium Access ESC Acute CardioVascular Care 2025 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Sonia Terriaca

Policlinico Tor Vergata, Rome (Italy)

5 More presentations in this session

Presentation thumbnail
Reservoir-excess pressure analysis, aiding critical care management by revealing subtle changes in vasomotor status, is closely linked to dicrotic notch morphology
Miss Y. Alan (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Use of landiolol for acute heart rate management in critically ill cardiac patients: a retrospective single-center experience
Doctor G. Tavecchia (Milan, IT)
Abstract Slides
Presentation thumbnail
Thromboembolic risk of electrical cardioversion in patients with cardiogenic shock
Doctor C. Scherer (Munich, DE)
Abstract Slides
Presentation thumbnail
Ensuring equity in acute aortic syndrome treatment
Doctor I. Ramos Gonzalez-Cristobal (Madrid, ES)
Abstract Slides
Presentation thumbnail
Unravelling the pathway to postoperative frailty in patients undergoing cardiac surgery: the serial mediating roles of kinesiophobia and sedentary time from illness perception
Miss C. Wong (Hong Kong, HK)
Abstract Slides

Access the full session

Session thumbnail
Embracing diversity in intensive cardiac care

The Event

Event poster

ESC Acute CardioVascular Care 2025

14 March 2025 12:55 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources